LaFrance Norman D. 4/A
4/A · PLUS THERAPEUTICS, INC. · Filed Mar 28, 2022
Insider Transaction Report
Form 4/AAmended
LaFrance Norman D.
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy shares of common stock)
[F1]2021-11-11+120,000→ 120,000 totalExercise: $1.71Exp: 2031-11-11→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]25% of the options will vest on November 11, 2022 with the remaining options vesting over the subsequent three years in equal monthly installments.
Signature
/s/ Andrew Sims, as attorney-in-fact|2022-03-28